ArticleOncology letters2013

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action.

Yaping Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.